IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Miragen Therapeutics Inc

CUSIP: 60463E103 | 121 institutional holders

Quarters

Q4 2020Q3 2020Q2 2020Q1 2020Q4 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2020

Driehaus Capital Management LLC33,333
0.0% of portfolio›$548
Sphera Funds Management Ltd.30,497
0.0% of portfolio›$502
StyleTurnoverLocationFiled
Driehaus Capital Management LLC
33,333$5480.0%GrowthHighChicago, IL2021-02-16
Sphera Funds Management Ltd.
30,497$5020.0%CoreHighTel Aviv, Luxembourg2021-02-16